Moltek A.Ş has been established in 2007 and launched radiopharmacutical production in 2009. Moltek is a pioneer in nuclear medicine market in Turkey. Its product range has been expanding regarding necessities of the market. Moltek delivers best quality of products and services by utilizing advanced technologies and expert staff in their field. For that matter, Moltek aims to be world's leading brand. Moltek produces radiopharmaceuticals, which compromise internatioanal standards, used for diagnosis and treatment. It provides reliable and high quality service by using Good Manufacturing Practice (GMP). With new investments and enterprises, Moltek is prepared for being globally known manufacturer.